FDA Requests Public Comment on New Guidelines for Antibiotic Resistance Monitoring

Summary

The US Food and Drug Administration (FDA) is seeking public input on new guidelines for monitoring antibiotic resistance, as part of the National Antimicrobial Resistance Monitoring System (NARMS). The meeting aims to discuss and gather feedback on the proposed changes to improve the nation's ability to track and address antibiotic resistance.